#IPR2026
LightNews LightNews
patseer.bsky.social
1 week to go for IPR India Summit 2026!

Meet PatSeer in Mumbai for AI-powered patent insights & live demos. bit.ly/4mCGOrf

#patseer #patents #patentlandscape #PatentPortfolio #aipatentsearch #Patentanalysis #PatentInsights #PatentDatabase #PatentAnalytics #IPR #IPR2026
8th Annual IPR India Summit 2026
June 18, 2026 at 8:37 AM
ip-law.bsky.social
PTAB Denies Institution of Additional Elevidys® Gene Therapy IPR
PTAB Denies Institution of Additional Elevidys® Gene Therapy IPR
On July 21, 2026, the Director of the U.S. Patent and Trademark Office issued a bulk Order denying institution on the merits of IPR2026-00270,...
www.jdsupra.com
August 3, 2026 at 3:58 PM
frank-jdsupra.bsky.social
PTAB Denies Institution of Additional Elevidys® Gene Therapy IPR
PTAB Denies Institution of Additional Elevidys® Gene Therapy IPR
On July 21, 2026, the Director of the U.S. Patent and Trademark Office issued a bulk Order denying institution on the merits of IPR2026-00270,...
www.jdsupra.com
August 3, 2026 at 3:58 PM
techlawjdsupra.bsky.social
PTAB Denies Institution of Additional Elevidys® Gene Therapy IPR
PTAB Denies Institution of Additional Elevidys® Gene Therapy IPR
On July 21, 2026, the Director of the U.S. Patent and Trademark Office issued a bulk Order denying institution on the merits of IPR2026-00270,...
www.jdsupra.com
August 3, 2026 at 3:58 PM
frank-jdsupra.bsky.social
Failure To Cite Own Prior Art Tanks Patent Owner’s Discretionary Denial Request
Failure To Cite Own Prior Art Tanks Patent Owner’s Discretionary Denial Request
In Microsoft Corporation v. Sandpiper CDN, LLC, IPR2026-00180 (Paper 15, May 6, 2026), Director Squires denied Sandpiper CDN’s request for...
www.jdsupra.com
September 9, 2026 at 6:54 PM
techlawjdsupra.bsky.social
Failure To Cite Own Prior Art Tanks Patent Owner’s Discretionary Denial Request
Failure To Cite Own Prior Art Tanks Patent Owner’s Discretionary Denial Request
In Microsoft Corporation v. Sandpiper CDN, LLC, IPR2026-00180 (Paper 15, May 6, 2026), Director Squires denied Sandpiper CDN’s request for...
www.jdsupra.com
September 9, 2026 at 6:54 PM
ip-law.bsky.social
Failure To Cite Own Prior Art Tanks Patent Owner’s Discretionary Denial Request
Failure To Cite Own Prior Art Tanks Patent Owner’s Discretionary Denial Request
In Microsoft Corporation v. Sandpiper CDN, LLC, IPR2026-00180 (Paper 15, May 6, 2026), Director Squires denied Sandpiper CDN’s request for...
www.jdsupra.com
September 9, 2026 at 6:54 PM
patentbuddy.bsky.social
www.ptablitigationblog.com/directors-vi...
Director’s View on Discretionary Denials: No “Second Bite at the Apple” - PTAB Litigation Blog
In Magnolia Medical Technologies, Inc. v. Kurin, Inc., IPR2026-00097 (“Decision”), Director Squires issued a precedential decision denying institution of inter partes review (“IPR”)—and in doing so, a...
www.ptablitigationblog.com
September 2, 2026 at 12:24 PM
ip-law.bsky.social
Director’s View on Discretionary Denials: No “Second Bite at the Apple”
Director’s View on Discretionary Denials: No “Second Bite at the Apple”
In Magnolia Medical Technologies, Inc. v. Kurin, Inc., IPR2026-00097 (“Decision”), Director Squires issued a precedential decision denying...
www.jdsupra.com
August 3, 2026 at 8:24 PM
ip-law.bsky.social
Amneal and Kashiv File First Xolair® (omalizumab) IPR
Amneal and Kashiv File First Xolair® (omalizumab) IPR
On May 26, 2026, Amneal and Kashiv filed IPR2026-00260 challenging Genentech’s U.S. Patent No. 12,030,959, which claims methods for treating food...
www.jdsupra.com
June 2, 2026 at 9:32 PM
ip-law.bsky.social
Amneal and Kashiv File IPR Petition on Omalizumab Patent
Amneal and Kashiv File IPR Petition on Omalizumab Patent
On May 26, 2026, Amneal Pharmaceuticals, Inc. and Kashiv Biosciences petitioned for inter partes review (IPR2026-00260) of all claims of U.S....
www.jdsupra.com
June 2, 2026 at 9:27 PM
frank-jdsupra.bsky.social
Amneal and Kashiv File First Xolair® (omalizumab) IPR
Amneal and Kashiv File First Xolair® (omalizumab) IPR
On May 26, 2026, Amneal and Kashiv filed IPR2026-00260 challenging Genentech’s U.S. Patent No. 12,030,959, which claims methods for treating food...
www.jdsupra.com
June 2, 2026 at 9:32 PM
health-law-news.bsky.social
Amneal and Kashiv File First Xolair® (omalizumab) IPR
Amneal and Kashiv File First Xolair® (omalizumab) IPR
On May 26, 2026, Amneal and Kashiv filed IPR2026-00260 challenging Genentech’s U.S. Patent No. 12,030,959, which claims methods for treating food...
www.jdsupra.com
June 2, 2026 at 9:32 PM
health-law-news.bsky.social
Amneal and Kashiv File IPR Petition on Omalizumab Patent
Amneal and Kashiv File IPR Petition on Omalizumab Patent
On May 26, 2026, Amneal Pharmaceuticals, Inc. and Kashiv Biosciences petitioned for inter partes review (IPR2026-00260) of all claims of U.S....
www.jdsupra.com
June 2, 2026 at 9:27 PM
patseer.bsky.social
Day 2 at IPR India Summit 2026 is all about meaningful IP conversations.

Great discussions around patent search, portfolio analytics, monitoring, and how AI is shaping smarter IP decision-making.

#patseer #patents #Patentanalysis #PatentDatabase #PatentAnalytics #IPR #IPR2026
IPR India Summit 2026
June 25, 2026 at 7:52 AM
patseer.bsky.social
Day 1 begins at the IPR India Summit 2026.

If you’re attending, stop by and connect with our team on smarter patent intelligence and IP strategy. bit.ly/4mCGOrf

#patseer #patents #patentlandscape #PatentPortfolio #aipatentsearch #Patentanalysis #PatentDatabase #PatentAnalytics #IPR #IPR2026
8th Annual IPR India Summit 2026
June 24, 2026 at 10:13 AM
techlawjdsupra.bsky.social
Amneal and Kashiv File First Xolair® (omalizumab) IPR
Amneal and Kashiv File First Xolair® (omalizumab) IPR
On May 26, 2026, Amneal and Kashiv filed IPR2026-00260 challenging Genentech’s U.S. Patent No. 12,030,959, which claims methods for treating food...
www.jdsupra.com
June 2, 2026 at 9:32 PM